|
|
Volumn 157, Issue , 2000, Pages 178-189
|
|
Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
BCG VACCINE;
BIOLOGICAL RESPONSE MODIFIER;
ADJUVANT CHEMOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
IMMUNOTHERAPY;
LIMB;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MELANOMA;
METASTASIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REGIONAL PERFUSION;
REOPERATION;
RETROSPECTIVE STUDY;
REVIEW;
SENTINEL LYMPH NODE BIOPSY;
SKIN TUMOR;
TREATMENT OUTCOME;
VASCULARIZATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BCG VACCINE;
BIOLOGICAL RESPONSE MODIFIERS;
CHEMOTHERAPY, ADJUVANT;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
CLINICAL TRIALS, PHASE III;
COMBINED MODALITY THERAPY;
EXTREMITIES;
HUMANS;
IMMUNOTHERAPY;
INTERFERON-ALPHA;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MELANOMA;
NEOPLASM STAGING;
RANDOMIZED CONTROLLED TRIALS;
REOPERATION;
RETROSPECTIVE STUDIES;
SENTINEL LYMPH NODE BIOPSY;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0033650083
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-57151-0_15 Document Type: Review |
|
Times cited : (38)
|
|
References (63)
|
